BerGenBio’s management team is composed of experienced biopharma executives with a drive for creating novel therapeutics for cancer. The Company’s management combine a wealth of talent and international experience in drug discovery, AXL cancer biology, and commercialisation.
Management Team
Martin Olin
Chief Executive Officer
Martin Olin joined BerGenBio as Chief Executive Officer in September…
Read More
Nigel McCracken (MSc, PhD)
Chief Scientific Officer
Dr. Nigel McCracken joined BerGenBio as Chief Scientific Officer in…
Read More
Dr E Gwyn Thomas (MD, BCh)
Interim Head of Clinical Development
Dr E. Gwyn Thomas joined BerGenBio in June 2021 as…
Read More
James Barnes (PhD)
Director of Operations
Dr James Barnes joined BerGenBio in March 2019 and is…
Read More
Professor Hani Gabra (MD, PHD, FRCPE, FRCP)
Director of Clinical Development
Professor Hani Gabra is BerGenBio’s Director of Clinical Development, based…
Read More
Alison Messom (PhD)
Director of Clinical Operations
Dr Alison Messom joined BerGenBio in June 2019 based in…
Read More
Gro Gausdal (PhD)
Director of Research & Bergen Site Leader
Dr Gro Gausdal joined BerGenBio in 2013 and holds the…
Read More
Endre Kjærland (PhD)
Associate Director of IP and Contracts
Dr Endre Kjærland joined BerGenBio ASA in 2011 and is…
Read More
Debbie Molyneux
Interim HR Director
Debbie Molyneux joined the Company in 2019 as Consultant for…
Read More
